Subject: COVID-19
Subject: oncology
Subject: radiotherapy
Year: 2020
Type: Article
Title: A review of the International Early Recommendations for Departments Organization and Cancer Management Priorities during the Global COVID-19 Pandemic. Applicability in Low- and Middle-Income Countries
Author: Belkacemi, Yazid
Author: Grellier, Noemie
Author: Ghith, Sahar
Author: Debbi, Kamel
Author: Coraggio, Gabriele
Author: Bounedjar, Adda
Author: Samlali, Redouane
Author: Tsoutsou, Pauletta G.
Author: Ozsahin, Mahmut
Author: Chauvet, Marie-Pierre
Author: Turkan, Sedat
Author: Boussen, Hamouda
Author: Kuten, Abraham
Author: Tesanovic, Dusanka
Author: Errihani, Hassan
Author: Benna, Farouk
Author: Bouzid, Kamel
Author: Idbaih, Ahmed
Author: Mokhtari, Karima
Author: Popovic, Lazar
Author: Spano, Jean-Philippe
Author: Lotz, Jean-Pierre
Author: Cherif, Aziz
Author: To, Hahn
Author: Kovcin, Vladimir
Author: Arsovski, Oliver
Author: Beslija, Semir
Author: Dzodic, Radan
Author: Markovic, Ivan
Author: Vasovic, Suzana
Author: Stamatovic, Liljana
Author: Radosavljevic, Davorin
Author: Radulovic, Sinisa
Author: Vrbanec, Damir
Author: Sahraoui, Souha
Author: Vasev, Nino
Author: Stojkovski, Igor
Author: Risteski, Milan
Author: Freixa, Salvador Villà
Author: Krengli, Marco
Author: Radosevic, Nina
Author: Mustacchi, Giorgio
Author: Filipovic, Mladen
Author: Kerrou, Khaldoun
Author: Taghian, Alphonse G.
Author: Todorovic, Vladimir
Author: Geara, Fady
Author: Gligorov, Joseph
Abstract: Coronavirus disease 2019 (COVID-19) is an infectious disease caused by a new virus that has never been identified in humans before. COVID-19 caused at the time of writing of this article, 2.5 million cases of infections in 193 countries with 165,000 deaths, including two-third in Europe. In this context, Oncology Departments of the affected countries had to adapt quickly their health system care and establish new organizations and priorities. Thus, numerous recommendations and therapeutic options have been reported to optimize therapy delivery to patients with chronic disease and cancer. Obviously, while these cancer care recommendations are immediately applicable in Europe, they may not be applicable in certain emerging and low and middle income countries (LMICs). In this review we aimed to summarize these international guidelines according to cancer types, making a synthesis for daily practice to protect patients, staff and tailor anti-cancer therapy delivery taking into account patients/tumor criteria and tools availability. Thus, we will discuss their applicability in the LMICs with different organizations, limited means and different constraints
Publisher: Elsevier BV
Relation: European Journal of Cancer
Identifier: oai:repository.ukim.mk:20.500.12188/8565
Identifier: http://hdl.handle.net/20.500.12188/8565Identifier: 10.1016/j.ejca.2020.05.015
